OPTN/SRTR 2020 Annual Data Report: Lung

M. Valapour, C. J. Lehr, M. A. Skeans, J. M. Smith, E. Miller, R. Goff, T. Mupfudze, K. Gauntt, J. J. Snyder

Research output: Contribution to journalArticlepeer-review

72 Scopus citations


For the first time in a decade, both the number of candidates added to the waiting list and the number of lung transplants performed decreased from the year prior; the number of lung donors also declined. This slowing of transplant activities in 2020 was associated with a modest increase in waitlist mortality. The year 2020 was notable for the global outbreak of the COVID-19 pandemic, which undoubtedly influenced all trends noted in lung transplantation. Time to transplant continued to decrease, with a median time to transplant of 1.4 months across all waitlist candidates. Posttransplant survival remained stable, with 89.4% of transplant recipients surviving to 1 year, 74.8% to 3 years, and 61.2% to 5 years.

Original languageEnglish (US)
Pages (from-to)438-518
Number of pages81
JournalAmerican Journal of Transplantation
Issue numberS2
StatePublished - Mar 2022

Bibliographical note

Publisher Copyright:
© John Wiley & Sons, Ltd.


  • End-stage lung disease
  • LAS
  • lung allocation score
  • lung transplant
  • organ allocation
  • revised lung allocation score
  • transplant outcomes


Dive into the research topics of 'OPTN/SRTR 2020 Annual Data Report: Lung'. Together they form a unique fingerprint.

Cite this